News

Tribute to Dr. David Seldin

David C. Seldin: Brilliant Scientist, Compassionate Clinician and Gifted Teacher With sadness we write to let you know that we have lost a distinguished professor, brilliant investigator, beloved physician, and beneficent leader. David C. Seldin, MD, PhD, director of the Amyloidosis Center at Boston University School of Medicine, died on June 27, of prostate cancer. He was […]

Bill Cunningham’s Race and Raffle to Beat Amyloid

Come celebrate Bill’s birthday at the 8th Annual Bill Cunningham Race and Raffle to Beat Amyloid Saturday, March 7th at Cannon Mountain Ski Race Registration online at https://development.bmc.org/billsrace Get friends & family to sponsor you ~ a full day ticket, t-shirt, glass, and invitation to post-race reception for top 15 fundraisers are included if you […]

Welcome Dr. Katie Bever and Allison Rosenberg, RN, DNP

We welcome Dr. Katherine (Katie) Bever and Ms. Allison Rosenberg. Katie (on the left) is a board-eligible internist joining us for the year as the “amyloid doctor”, replacing Dr. Julie Fu, who has left us to pursue further training in hematology-oncology; we wish her well! Dr. Bever is also interested in going into hematology-oncology, after […]

Anne Alllaire Art Exhibit

Talented artist Anne Gable Allaire, a 17 year AL amyloidosis survivor, has an upcoming one woman show at the Maine State Capitol in Augusta on view now through June 9, 2014. Anne is a Master Pastelist and member of the Pastel Society of America. Her work can be previewed on their website or seen  at […]

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

December 25, 2013 An international consortium of investigators led by Amyloidosis Center Clinical Director Dr. John Berk have completed a randomized, placebo-controlled, phase III clinical trial of the non-steroidal anti-inflammatory drug diflunisal for patients with ATTR polyneuropathy, published today in the Journal of the American Medical Association. 130 participating patients received either diflunisal (250 mg […]